Relapse and rehospitalization: comparing oral and depot antipsychotics.

摘要: A review of studies that compared conventional oral and depot antipsychotic medications highlighted the following points. Mirror-image in which patients served as their own controls provided evidence substantial benefit for injectable medications. The randomized clinical trials did not, general, support findings significant decrease relapse rates between these 2 routes administration. Across reviewed, 1-year rate long-acting medication was 27% with 42% who received medication. risk guaranteed suggests is not always driven by noncompliance. In only study lasted years, decreased substantially depot-treated patients, suggesting noncompliance may be a more important factor over extended periods time. recent formal meta-analytic concluded this route administration resulted advantages terms global outcome.